- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04480931
Pilot Testing a Mobile App to Designed to Increase Physical Activity Among Pregnant and Postpartum Women
Pilot Testing of a Mobile Health Intervention Designed to Increase Physical Activity and Improve Morbidity and Mortality-related Outcomes Among Pregnant and Postpartum Women in a Rural Setting
The goal of this pilot project is to test the feasibility and potential efficacy of the evidence-based mHealth app (BumptUp) for improving physical activity and subsequent health outcomes (i.e. obesity, hypertension, insulin resistance) among pregnant and postpartum women in a rural community.
In order to accomplish this goal, feasibility of the intervention protocol will be tested by the assessment of recruitment (how many participants eligible per month), retention (% of women who complete the study protocol), adherence to intervention (% of women who utilize the app), and acceptability (survey and one-on-one exit interviews) during pregnancy and postpartum.
Potential efficacy will be determined by examining trends in data on physical activity levels (achieving the goal of 150 minutes per week of physical activity (surveys and accelerometry)) between groups. Other secondary outcomes will also be assessed: weight status, body composition, blood pressure, insulin resistance, fitness levels, mental health, and infant anthropometrics.
Clinical hypotheses:
- The mHealth program will be feasible as evidenced by high rates of enrollment, retention, and adherence, moderate-to-high levels of satisfaction, and low participant burden.
- The mHealth intervention will show promise towards improving physical activity levels and other secondary outcomes in pregnant and postpartum women in a rural community.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
After contact is established and eligibility confirmed, Participants (N=40) will be enrolled and baseline surveys will be conducted to collect information about lifestyle, mental health, and anxiety levels. Patient data for those participants who have agreed to be in the study and have specifically agreed on the consent form to allow the study team to pull data from their prenatal charts. The data being pulled from charts will include patient weights, vital signs, blood pressures, current complications, blood analytes, and glucose tolerance test results from each prenatal visit. After the baby is born, delivery reports will also be obtained in order to collect information on the delivery outcomes (gender, mode of delivery, complications, time in labor) and baby's anthropometric data (birthweight, birth length, head circumference).
Compensation will be in the form of Amazon gift cards (delivered electronically). There will be 4 time points where they take the online assessments. At each time point, they will also be mailed an Actigraph accelerometer to wear for one week. These will be sanitized and mailed or dropped off to avoid any contamination from the study team to participants. When the week is over, the study team will check in with participants and discuss a plan for pick up. They can leave outside for a study team member to pick up (contactless ) or they can mail it back (with provided return envelope).
Each participant will still receive a total of $160. They be recruited and consented online around 18-20 weeks. Assessments will occur at 4 timepoints: baseline assessments at 23-25 weeks gestation ($40), phone check at 30 weeks, second assessment/set of surveys at 35-37 weeks ($40), delivery outcomes obtained, 6 week postpartum surveys ($40), and 12 week postpartum surveys ($40).
Statistical Analyses:
Sample Size Determination: Sample size for this pilot study was determined based on previously performed physical activity interventions among pregnant women. The effect size (0.91) for the main outcome of physical activity was determined from looking at post-intervention physical activity data from Asci et al.83. With this effect size, it was determined using SAS software with a type I error rate of 0.05 that a sample size of 20 per group could detect this difference with 80% power, thus our sample size of 15 per group is justified for a pilot project.
Data Analyses:
Aim 1: To estimate the success and feasibility of recruitment methods, the number of people who will hear about the study via various methods (e.g. health care providers, health fairs, word-of-mouth) will be estimated. Then, the number of women who completed initial screening, the number of women who meet the eligibility criteria, the number of women who complete each of the assessments, the number of women randomized, and the number of women who adhere to the intervention will be determined. The exit interview data will be analyzed via standard content analyses for qualitative studies as previously described84 (and recently performed by our group). Aim 2: Although the investigators may not detect all between group differences because the investigators are proposing a pilot project, appropriate statistical tests will be performed in order to examine trends, and thus, promise for effect in the larger future trial. Normality of the distribution for each variable will be tested using Kolmogorov-Smirnov tests, and non-normally distributed data will be transformed as needed. The baseline characteristics of the two groups will be compared using t-tests or Chi square tests. The potential effect of the intervention on study outcomes will be explored using repeated measures ANOVAs (group x time). Specifically, physical activity data between groups will be compared from pre-post intervention. All data will be entered in Redcap data management system. Analyses will be conducted using SAS or other statistical software.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kentucky
-
Bowling Green, Kentucky, United States, 42101
- Western Kentucky University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 1) Age 18-44
- 2) Confirmed singleton viable pregnancy
- 3) English-Speaking (the app is currently only available in English)
- 4) Physician release to participate in exercise
- 5) Ownership of a smart phone
- 6) Plans to deliver at The Medical Center in Bowling Green, KY.
Exclusion Criteria:
- 1) Multiple gestation pregnancy
- 2) Inability to provide voluntary informed consent
- 3) Any medical condition (pregnancy-related or not) that would preclude exercise.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: mHealth Intervention Group
This group will be provided with the mobile health app (including introductory videos on how to use its features).
|
Access to the mobile health application with exercise plans and education
|
Sham Comparator: Control Group
This group will receive an educational brochure about physical activity during pregnancy.
|
An evidence-based educational brochure with general information about the benefits of physical activity during pregnancy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recruitment feasibility during pregnancy
Time Frame: Pregnancy (23-25 weeks gestation)
|
how many participants eligible and successfully recruited per month
|
Pregnancy (23-25 weeks gestation)
|
Protocol retention
Time Frame: 12 weeks postpartum
|
% of women who complete the study protocol
|
12 weeks postpartum
|
Adherence to intervention
Time Frame: Pregnancy (35-37 weeks pregnant)
|
% of women who use the app daily
|
Pregnancy (35-37 weeks pregnant)
|
Adherence to intervention
Time Frame: Postpartum (12 weeks after delivery)
|
% of women who use the app daily
|
Postpartum (12 weeks after delivery)
|
Acceptability of Intervention
Time Frame: Postpartum (12 weeks after delivery)
|
measured via exit interviews
|
Postpartum (12 weeks after delivery)
|
Physical activity levels
Time Frame: Pregnancy (23-25 weeks gestation)
|
Assess the potential efficacy of the intervention by examining physical activity levels through objective actigraph data
|
Pregnancy (23-25 weeks gestation)
|
Physical activity levels
Time Frame: Pregnancy (35-37 weeks gestation)
|
Assess the potential efficacy of the intervention by examining physical activity levels through objective actigraph data
|
Pregnancy (35-37 weeks gestation)
|
Physical activity levels
Time Frame: Postpartum (12 weeks)
|
Assess the potential efficacy of the intervention by examining physical activity levels through objective actigraph data
|
Postpartum (12 weeks)
|
Physical activity levels
Time Frame: Postpartum (6 weeks)
|
Assess the potential efficacy of the intervention by examining physical activity levels through Exercise Vital Sign Survey
|
Postpartum (6 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maternal weight status
Time Frame: Pregnancy (23-25 weeks gestation)
|
Body weight (lbs)
|
Pregnancy (23-25 weeks gestation)
|
Maternal weight status
Time Frame: Pregnancy (35-37 weeks gestation)
|
Body weight (lbs)
|
Pregnancy (35-37 weeks gestation)
|
Maternal weight status
Time Frame: Postpartum (12 weeks post-delivery)
|
Body weight (lbs)
|
Postpartum (12 weeks post-delivery)
|
Maternal blood pressure
Time Frame: Pregnancy (23-25 weeks gestation)
|
Assessed by nurse at clinical visit using standardized clinical equipment
|
Pregnancy (23-25 weeks gestation)
|
Maternal blood pressure
Time Frame: Pregnancy (35-37 weeks gestation)
|
Assessed by nurse at clinical visit using standardized clinical equipment
|
Pregnancy (35-37 weeks gestation)
|
Maternal blood pressure
Time Frame: Postpartum (6 weeks post-delivery)
|
Assessed by nurse at clinical using standardized clinical equipment
|
Postpartum (6 weeks post-delivery)
|
Maternal insulin resistance
Time Frame: Pregnancy (24-29 weeks gestation)
|
Oral Glucose Tolerance Test Results
|
Pregnancy (24-29 weeks gestation)
|
Maternal endothelial dysfunction
Time Frame: Pregnancy (35-37 weeks gestation)
|
Assessed with a rapid, non-invasive technique that records endothelium-mediated changes in the peripheral arterial tone signal via a pair of finger probes
|
Pregnancy (35-37 weeks gestation)
|
Maternal postpartum depression
Time Frame: Postpartum (12 weeks post-delivery)
|
Edinburgh postpartum depression survey
|
Postpartum (12 weeks post-delivery)
|
Maternal mood
Time Frame: Pregnancy (23-25 weeks gestation)
|
Profile of Mood Survey
|
Pregnancy (23-25 weeks gestation)
|
Maternal mood
Time Frame: Pregnancy (35-37 weeks gestation)
|
Profile of Mood Survey
|
Pregnancy (35-37 weeks gestation)
|
Maternal mood
Time Frame: Postpartum (6 weeks post-delivery)
|
Profile of Mood Survey
|
Postpartum (6 weeks post-delivery)
|
Maternal mood
Time Frame: Postpartum (12 weeks post-delivery)
|
Profile of Mood Survey
|
Postpartum (12 weeks post-delivery)
|
Mental Health
Time Frame: Pregnancy (23-25 weeks gestation)
|
Center for Epidemiological Studies Depression Survey
|
Pregnancy (23-25 weeks gestation)
|
Mental Health
Time Frame: Pregnancy (35-37 weeks gestation)
|
Center for Epidemiological Studies Depression Survey
|
Pregnancy (35-37 weeks gestation)
|
Mental Health
Time Frame: Postpartum (6 weeks post-delivery)
|
Center for Epidemiological Studies Depression Survey
|
Postpartum (6 weeks post-delivery)
|
Mental Health
Time Frame: Postpartum (12 weeks post-delivery)
|
Center for Epidemiological Studies Depression Survey
|
Postpartum (12 weeks post-delivery)
|
Infant birthweight
Time Frame: At time of delivery
|
Collected at delivery by trained nursing staff
|
At time of delivery
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 20-257
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Turku University HospitalUniversity of TurkuCompleted
-
Hopital Antoine BeclereUnknown
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
Clinical Trials on mHealth Intervention Group
-
Johns Hopkins UniversityCompletedChronic Kidney Diseases | Communication | Adherence, MedicationUnited States
-
Centro de Estudio de Estado y SociedadWithdrawn
-
University of California, San DiegoNational Institute on Drug Abuse (NIDA)Not yet recruiting
-
University of ConnecticutNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Liverpool John Moores UniversityLiverpool Heart and Chest Hospital NHS Foundation Trust; University Hospitals... and other collaboratorsRecruiting
-
The Hong Kong Polytechnic UniversityThe University of Hong Kong; Kwong Wah Hospital; University of Glasgow; Tsan Yuk...RecruitingQuality of Life | Family Relations | Postnatal DepressionHong Kong
-
Children's National Research InstituteNot yet recruitingSexually Transmitted Diseases
-
Kaiser PermanenteCompletedSmoking | Smoking CessationUnited States
-
KU LeuvenJomo Kenyatta University of Agriculture and TechnologyCompleted
-
University of FloridaCompleted